<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35734086</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2693-5015</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2022</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Research square</Title><ISOAbbreviation>Res Sq</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 infection of human brain microvascular endothelial cells leads to inflammatory activation through NF-&#x3ba;B non-canonical pathway and mitochondrial remodeling.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">rs.3.rs-1762855</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21203/rs.3.rs-1762855/v1</ELocationID><Abstract><AbstractText>Neurological effects of COVID-19 and long-COVID-19 as well as neuroinvasion by SARS-CoV-2 still pose several questions and are of both clinical and scientific relevance. We described the cellular and molecular effects of the human brain microvascular endothelial cells (HBMECs) <i>in vitro</i> infection by SARS-CoV-2 to understand the underlying mechanisms of viral transmigration through the Blood-Brain Barrier. Despite the low to non- productive viral replication, SARS-CoV-2-infected cultures displayed increased apoptotic cell death and tight junction protein expression and immunolocalization. Transcriptomic profiling of infected cultures revealed endothelial activation via NF-&#x3ba;B non-canonical pathway, including RELB overexpression, and mitochondrial dysfunction. Additionally, SARS-CoV-2 led to altered secretion of key angiogenic factors and to significant changes in mitochondrial dynamics, with increased mitofusin-2 expression and increased mitochondrial networks. Endothelial activation and remodeling can further contribute to neuroinflammatory processes and lead to further BBB permeability in COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torices</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Miami Miller School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta</LastName><ForeName>Carolline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fundacao Oswaldo Cruz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Rosa</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Fundacao Oswaldo Cruz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcos</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundacao Oswaldo Cruz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez-Rosa</LastName><ForeName>Liandra</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fundacao Oswaldo Cruz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Rodriguez</LastName><ForeName>Thaidy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of California San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matos</LastName><ForeName>Aline</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de V&#xed;rus Respirat&#xf3;rio e do Sarampo, Instituto Oswaldo Cruz, Funda&#xe7;&#xe3;o Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caetano</LastName><ForeName>Braulia</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Fundacao Oswaldo Cruz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fundacao Oswaldo Cruz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gladulich</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fundacao Oswaldo Cruz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loiola</LastName><ForeName>Erick</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7926-795X</Identifier><AffiliationInfo><Affiliation>Fluminense Federal University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagshaw</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Brock University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brock University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Marilda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Oswaldo Cruz Foundation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stipursky</LastName><ForeName>Joice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toborek</LastName><ForeName>Michal</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4475-2119</Identifier><AffiliationInfo><Affiliation>University of Miami.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adesse</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7421-9510</Identifier><AffiliationInfo><Affiliation>Instituto Oswaldo Cruz.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH128022</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA044579</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL126559</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA039576</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA050528</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA040537</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 MH122235</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA047157</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH072567</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Sq</MedlineTA><NlmUniqueID>101768035</NlmUniqueID><ISSNLinking>2693-5015</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Viruses. 2023 Mar 14;15(3):745. doi: 10.3390/v15030745</RefSource><PMID Version="1">36992454</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>2</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35734086</ArticleId><ArticleId IdType="pmc">PMC9216729</ArticleId><ArticleId IdType="doi">10.21203/rs.3.rs-1762855/v1</ArticleId><ArticleId IdType="pii">rs.3.rs-1762855</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Otsu N. A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern. 1979;9(1):62&#x2013;66.</Citation></Reference><Reference><Citation>Valente AJ, Maddalena LA, Robb EL, Moradi F, Stuart JA. A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem. 2017. Doi:10.1016/j.acthis.2017.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acthis.2017.03.001</ArticleId><ArticleId IdType="pubmed">28314612</ArticleId></ArticleIdList></Reference><Reference><Citation>Arganda-Carreras I, Fern&#xe1;ndez-Gonz&#xe1;lez R, Mu&#xf1;oz-Barrutia A, Ortiz-De-Solorzano C. 3D reconstruction of histological sections: Application to mammary gland tissue. Microsc Res Tech. 2010. Doi:10.1002/jemt.20829</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.20829</ArticleId><ArticleId IdType="pubmed">20232465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TC, Kashyap RL, Chu CN. Building Skeleton Models via 3-D Medial Surface Axis Thinning Algorithms. CVGIP Graph Model Image Process. 1994. Doi:10.1006/cgip.1994.1042</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cgip.1994.1042</ArticleId></ArticleIdList></Reference><Reference><Citation>HISAT2: Kim D, Langmead B and Salzberg SL. (2015) HISAT: a fast spliced aligner with low memory requirements. Nature Methods. http://ccb.jhu.edu/software/hisat2/index.shtml</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655817</ArticleId><ArticleId IdType="pubmed">25751142</ArticleId></ArticleIdList></Reference><Reference><Citation>featureCounts: Liao Y, Smyth GK and Shi W (2014). featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics, 30(7):923&#x2013;30. http://bioinf.wehi.edu.au/featureCounts/</Citation><ArticleIdList><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y. &amp; Hochberg Y. (1995) Controlling the False Discover Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B. 57: 289&#x2013;300</Citation></Reference><Reference><Citation>https://www.cdc.gov &#x203a; covid-data</Citation></Reference><Reference><Citation>https://data.cdc.gov &#x203a; Case-Surveillance &#x203a;</Citation></Reference><Reference><Citation>Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5, 536&#x2013;544, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095448</ArticleId><ArticleId IdType="pubmed">32123347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu R Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China N Engl J Med 382, 727&#x2013;733, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni J, Xiao S, Li X, Sun L. ACE gene missense mutation in a case with early-onset, rapid progressing dementia. Gen Psychiatr 32, e100028, 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802971</ArticleId><ArticleId IdType="pubmed">31673674</ArticleId></ArticleIdList></Reference><Reference><Citation>Torices S, Cabrera R, Stangis M, Naranjo O, Fattakhov N, Teglas T, Adesse D, Toborek M. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection. J Neuroinflammation 18, 67, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8319595</ArticleId><ArticleId IdType="pubmed">34325716</ArticleId></ArticleIdList></Reference><Reference><Citation>Torices S., Cabrera R., Stangis M., Naranjo O., Fattakhov N., Teglas T., Adesse D., &amp; Toborek M. (2021). Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection. Journal of neuroinflammation, 18(1), 167. 10.1186/s12974-021-02210-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02210-2</ArticleId><ArticleId IdType="pmc">PMC8319595</ArticleId><ArticleId IdType="pubmed">34325716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M&#xfc;ller MA, Drosten C, P&#xf6;hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271&#x2013;280 e8, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270&#x2013;273, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol 85, 873&#x2013;882, 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3020023</ArticleId><ArticleId IdType="pubmed">21068237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipeto D, Palmeira JDF, Arganaraz GA, Arganaraz ER. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19. Front Immunol 11, 576745, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575774</ArticleId><ArticleId IdType="pubmed">33117379</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber B, Patel A, Verma A. Shedding Light on COVID-19: ADAM17 the Missing Link? Am J Ther. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32769398</ArticleId></ArticleIdList></Reference><Reference><Citation>Solerte SB, Di Sabatino A, Galli M, Fiorina P. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetol 57, 779&#x2013;783, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275134</ArticleId><ArticleId IdType="pubmed">32506195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? J Diabetes 12, 649&#x2013;658, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32394639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C, Huang C, Zhou W, Ji X, Zhang F, Wang L, Zhou Y, Cui Q. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells. IEEE/ACM Trans Comput Biol Bioinform. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32750889</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa AK, Magalhaes DA, Ferreira JDS, Barbosa A. SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier. Med Hypotheses 144, 110213, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449115</ArticleId><ArticleId IdType="pubmed">33254519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du R Wei D, Zhang Y, Sun XX, Gong L, Yang X, He L, Zhang L, Yang Z, Geng JJ, Chen R, Zhang H, Wang B, Zhu YM, Nan G, Jiang JL, Li L, Wu J, Lin R Huang W, Xie L, Zheng ZH, Zhang K, Miao JL, Cui HY, Huang M, Zhang J, Fu L, Yang XM, Zhao Z, Sun S, Gu H, Wang Z, Wang CF, Lu Y, Liu YY, Wang QY, Bian H, Zhu P Chen ZN. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 5, 283, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao J, Li W, Bao J, Peng Q, Wen D, Wang J, Sun B. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues. Biochem Biophys Res Commun 533, 867&#x2013;871, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489930</ArticleId><ArticleId IdType="pubmed">33008593</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun 526, 135&#x2013;140, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanabhan P, Desikan R, Dixit NM. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. PloS Comput Biol 16, e1008461, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7748278</ArticleId><ArticleId IdType="pubmed">33290397</ArticleId></ArticleIdList></Reference><Reference><Citation>IstIfl IE, SihoGlu Tepe A, SarikUrkc UC, Tepe B. Interaction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic properties. Turk J Biol 44, 242&#x2013;264, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314502</ArticleId><ArticleId IdType="pubmed">32595360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol 19, 767&#x2013;783, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77, 683&#x2013;690, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, Adams G, Hornick JL, Padera RF Jr, Sabeti P. Neuropathological Features of Covid-19. N Engl J Med 383, 989&#x2013;992, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Virhammar J, Kumlien E, F&#xe4;llmar D, Frithiof R, Jackmann S, Sk&#xf6;ld MK, Kadir M, Frick J, Lindeberg J, Olivero-Reinius H, Ryttlefors M, Cunningham JL, Wikstr&#xf6;m J, Grabowska A, Bondeson K, Bergquist J, Zetterberg H, Rostami E.Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology 95, 445&#x2013;449, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538220</ArticleId><ArticleId IdType="pubmed">32586897</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci 11, 995&#x2013;998, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, Wang D, Mao L, Jin H, Hu B. 2020a. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5, 279&#x2013;284,.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Liu T, Yang N, Han D, Mi X, Li Y, Liu K, Vuylsteke A, Xiang H, Guo X. 2020b. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med 14, 533&#x2013;541,.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197033</ArticleId><ArticleId IdType="pubmed">32367431</ArticleId></ArticleIdList></Reference><Reference><Citation>Briguglio M, Bona A, Porta M, Dell&#x2019;Osso B, Pregliasco FE, Banfi G. Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes. Front Physiol 11, 671, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292028</ArticleId><ArticleId IdType="pubmed">32581854</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam SB, Willows S, Kulka M, Sandhu JK.Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur J Neurol 27, 2348&#x2013;2360, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405269</ArticleId><ArticleId IdType="pubmed">32668062</ArticleId></ArticleIdList></Reference><Reference><Citation>Achar A, Ghosh C. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance. Cells 9, 2360, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692725</ArticleId><ArticleId IdType="pubmed">33120941</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott NJ. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25, 5&#x2013;23, 2005.</Citation><ArticleIdList><ArticleId IdType="pubmed">15962506</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R, Hale JF, Galie PA, Potula R, Andrews AM, Ramirez SH. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 146, 105131, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Stins M. E., Badger J., &amp; Sik Kim K. (2001). Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microbial pathogenesis, 30(1), 19&#x2013;28. 10.1006/mpat.2000.0406</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mpat.2000.0406</ArticleId><ArticleId IdType="pubmed">11162182</ArticleId></ArticleIdList></Reference><Reference><Citation>https://.1</Citation></Reference><Reference><Citation>Matos AR, Caetano BC, de Almeida Filho JL, Martins JSCC, de Oliveira MGP, Sousa TdC, Horta MAP, Siqueira MM and Fernandez JH (2022) Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity. Front. Microbiol. 13:828984. Doi: 10.3389/fmicb.2022.828984</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.828984</ArticleId><ArticleId IdType="pmc">PMC8866965</ArticleId><ArticleId IdType="pubmed">35222340</ArticleId></ArticleIdList></Reference><Reference><Citation>Terryn C., Sellami M., Fichel C., Diebold M. D., Gangloff S., Le Naour R., Polette M., Zahm e J. M.. 2013. &#x201c;Rapid method of quantification of tight-junction organization using image analysis&#x201d;. Cytometry A 83 (2): 235&#x2013;41. 10.1002/cyto.a.22239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.22239</ArticleId><ArticleId IdType="pubmed">23212973</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., Kolehmainen P., Kakkola L., Maljanen S., Mel&#xe9;n K., Smura T., Julkunen I., &amp; &#xd6;sterlund P. (2021). SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Microbiology spectrum, 9(1), e0077421. 10.1128/Spectrum.00774-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00774-21</ArticleId><ArticleId IdType="pmc">PMC8552721</ArticleId><ArticleId IdType="pubmed">34378952</ArticleId></ArticleIdList></Reference><Reference><Citation>Mockenhaupt K., Gonsiewski A., &amp; Kordula T. (2021). RelB and Neuroinflammation. Cells, 10(7), 1609. 10.3390/cells10071609</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071609</ArticleId><ArticleId IdType="pmc">PMC8307460</ArticleId><ArticleId IdType="pubmed">34198987</ArticleId></ArticleIdList></Reference><Reference><Citation>Presta M, Foglio E, Churruca Schuind A, Ronca R. Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2. Front Immunol. 2018. Oct 8;9:2327. Doi: 10.3389/fimmu.2018.02327.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02327</ArticleId><ArticleId IdType="pmc">PMC6187966</ArticleId><ArticleId IdType="pubmed">30349543</ArticleId></ArticleIdList></Reference><Reference><Citation>Estato V., Stipursky J., Gomes F., Mergener T. C., Fraz&#xe3;o-Teixeira E., Allodi S., Tibiri&#xe7;&#xe1; E., Barbosa H. S., &amp; Adesse D. (2018). The Neurotropic Parasite Toxoplasma gondii Induces Sustained Neuroinflammation with Microvascular Dysfunction in Infected Mice. The American journal of pathology, 188(11), 2674&#x2013;2687. 10.1016/j.ajpath.2018.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2018.07.007</ArticleId><ArticleId IdType="pubmed">30121257</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H., Tan J., Wang R., Wan H., He Y., Yan X., Guo J., Gao Q., Li J., Shang S., Chen F., Tian R., Liu W., Liao L., Tang B., &amp; Zhang Z., (2020). PINK1 phosphorylates Drp1S616 to regulate mitophagy-independent mitochondrial dynamics. EMBO reports, 21(8), e48686. 10.15252/embr.201948686</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201948686</ArticleId><ArticleId IdType="pmc">PMC7403662</ArticleId><ArticleId IdType="pubmed">32484300</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken I. R., Saginc G., He L., Huseynov A., Daniels A., Fletcher S., Peghaire C., Kalna V., Andaloussi-M&#xe4;e M., Muhl L., Craig N. M., Griffiths S. J., Haas J. G., Tait-Burkard C., Lendahl U., Birdsey G. M., Betsholtz C., Noseda M., Baker A. H., &amp; Randi A. M. (2021). Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells. Circulation, 143(8), 865&#x2013;868. 10.1161/CIRCULATIONAHA.120.052824</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052824</ArticleId><ArticleId IdType="pmc">PMC7899720</ArticleId><ArticleId IdType="pubmed">33405941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento Conde J., Schutt W. R., Gorbunova E. E., &amp; Mackow E. R. (2020). Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses. mBio, 11(6), e03185&#x2013;20. 10.1128/mBio.03185-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03185-20</ArticleId><ArticleId IdType="pmc">PMC7751258</ArticleId><ArticleId IdType="pubmed">33310781</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuberger J., Trimpert J., Vladimirova D., Goosmann C., Lin M., Schmuck R., Mollenkopf H. J., Brinkmann V., Tacke F., Osterrieder N., &amp; Sigal M. (2021). Epithelial response to IFN-&#x3b3; promotes SARS-CoV-2 infection. EMBO molecular medicine, 13(4), e13191. 10.15252/emmm.202013191</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013191</ArticleId><ArticleId IdType="pmc">PMC7995094</ArticleId><ArticleId IdType="pubmed">33544398</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuren L. M., Prestes E. B., Papa M. P., de Carvalho L., Mustaf&#xe1; Y. M., da Costa L. S., Da Poian A. T., Bozza M. T., &amp; Arruda L. B. (2022). Infection of Endothelial Cells by Dengue Virus Induces ROS Production by Different Sources Affecting Virus Replication, Cellular Activation, Death and Vascular Permeability. Frontiers in immunology, 13, 810376. 10.3389/fimmu.2022.810376</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.810376</ArticleId><ArticleId IdType="pmc">PMC8847576</ArticleId><ArticleId IdType="pubmed">35185902</ArticleId></ArticleIdList></Reference><Reference><Citation>Leda A. R., Bertrand L., Andras I. E., El-Hage N., Nair M., &amp; Toborek M. (2019). Selective Disruption of the Blood-Brain Barrier by Zika Virus. Frontiers in microbiology, 10, 2158. 10.3389/fmicb.2019.02158</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.02158</ArticleId><ArticleId IdType="pmc">PMC6759472</ArticleId><ArticleId IdType="pubmed">31620112</ArticleId></ArticleIdList></Reference><Reference><Citation>Mladinich M. C., Conde J. N., Schutt W. R., Sohn S. Y., &amp; Mackow E. R. (2021). Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells. mBio, 12(4), e0196221. 10.1128/mBio.01962-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01962-21</ArticleId><ArticleId IdType="pmc">PMC8406327</ArticleId><ArticleId IdType="pubmed">34399621</ArticleId></ArticleIdList></Reference><Reference><Citation>DeOre B. J., Tran K. A., Andrews A. M., Ramirez S. H., &amp; Galie P. A. (2021). SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation. Journal of neuroimmune pharmacology: the official journal of the Society on Neuroimmune Pharmacology, 16(4), 722&#x2013;728. 10.1007/s11481-021-10029-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10029-0</ArticleId><ArticleId IdType="pmc">PMC8536479</ArticleId><ArticleId IdType="pubmed">34687399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao S., Ning K., Kuz C. A., Vorhies K., Yan Z., &amp; Qiu J. (2020). Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium. mBio, 11(6), e02852&#x2013;20. 10.1128/mBio.02852-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02852-20</ArticleId><ArticleId IdType="pmc">PMC7649230</ArticleId><ArticleId IdType="pubmed">33158999</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauti R., Shahoha M., Leichtmann-Bardoogo Y., Nasser R., Paz E., Tamir R., Miller V., Babich T., Shaked K., Ehrlich A., Ioannidis K., Nahmias Y., Sharan R., Ashery U., &amp; Maoz B. M. (2021). Effect of SARS-CoV-2 proteins on vascular permeability. eLife, 10, e69314. 10.7554/eLife.69314</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69314</ArticleId><ArticleId IdType="pmc">PMC8545399</ArticleId><ArticleId IdType="pubmed">34694226</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta S., &amp; Bandyopadhyay M. (2021). Molecular docking of SARS-COV-2 Spike epitope sequences identifies heterodimeric peptide-protein complex formation with human Zo-1, TLR8 and brain specific glial proteins. Medical hypotheses, 157, 110706. 10.1016/j.mehy.2021.110706</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110706</ArticleId><ArticleId IdType="pmc">PMC8511551</ArticleId><ArticleId IdType="pubmed">34673372</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillet-Saguy C., &amp; Wolff N. (2021). PDZ-Containing Proteins Targeted by the ACE2 Receptor. Viruses, 13(11), 2281. 10.3390/v13112281</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112281</ArticleId><ArticleId IdType="pmc">PMC8624105</ArticleId><ArticleId IdType="pubmed">34835087</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S., Zou L., Wang H., He R., Liu K., &amp; Zhu H. (2018). RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability. Molecules (Basel, Switzerland), 23(9), 2371. 10.3390/molecules23092371</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23092371</ArticleId><ArticleId IdType="pmc">PMC6225311</ArticleId><ArticleId IdType="pubmed">30227623</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant O., Barthelemy J., Bollor&#xe9; K., Tuaillon E., Gosselet F., Chable-Bessia C., Merida P., Muriaux D., Van de Perre P., Salinas S., &amp; Simonin Y. (2021). SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Frontiers in immunology, 12, 697329. 10.3389/fimmu.2021.697329</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.697329</ArticleId><ArticleId IdType="pmc">PMC8353323</ArticleId><ArticleId IdType="pubmed">34386007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W.,Wei Q., Xu Y., Deng W., Gao H., Xue J., Song Z., Yu P., Han Y., Zhang Y.,Sun X., Yu X., &#x2026; Qin C. (2021). SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal transduction and targeted therapy, 6(1), 337. 10.1038/s41392-021-00719-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M. S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., Hartmann K., Thies E., Littau J. L., Sepulveda-Falla D., Zhang L., Ton K., Liang Y., Matschke J.,Ricklefs F., Sauvigny T., &#x2026; Pless O. (2022). The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem cell reports, 17(2),307&#x2013;320. 10.1016/j.stemcr.2021.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S. C. (2012). The noncanonical NF-&#x3ba;B pathway. Immunological reviews, 246(1), 125&#x2013;140. 10.1111/j.1600-065X.2011.01088.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2011.01088.x</ArticleId><ArticleId IdType="pmc">PMC3313452</ArticleId><ArticleId IdType="pubmed">22435551</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J., Lampe J., M&#xfc;ller-Fielitz H., Schuster R., Zille M., M&#xfc;ller K., Krohn M., K&#xfc;rbelin J., Zhang L., &#xd6;zorhan &#xdc;., Neve V., Wagner J., Bojkova D., Shumliakivska M., Jiang Y., F&#xe4;hnrich A., Ott F., Sencio V., Robil C., Pfefferle S., &#x2026; Schwaninger M. (2021). The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nature neuroscience, 24(11), 1522&#x2013;1533.10.1038/s41593-021-00926-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Mockenhaupt K., Gonsiewski A., &amp; Kordula T. (2021). RelB and Neuroinflammation. Cells, 10(7), 1609. 10.3390/cells10071609</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071609</ArticleId><ArticleId IdType="pmc">PMC8307460</ArticleId><ArticleId IdType="pubmed">34198987</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih V. F., Davis-Turak J., Macal M., Huang J. Q., Ponomarenko J., Kearns J. D., Yu T., Fagerlund R., Asagiri M., Zuniga E. I., &amp; Hoffmann A. (2012). Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-&#x3ba;B pathways. Nature immunology, 13(12), 1162&#x2013;1170. 10.1038/ni.2446</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2446</ArticleId><ArticleId IdType="pmc">PMC3634611</ArticleId><ArticleId IdType="pubmed">23086447</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X.; El Gazzar M.; Yoza B.K.; McCall C.E. The NF-&#x3ba;B factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J. Biol. Chem. 2009, 284, 27857&#x2013;27865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2788836</ArticleId><ArticleId IdType="pubmed">19690169</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T.F.; Yoza B.K.; El Gazzar M.; Vachharajani V.T.; McCall C.E. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 2011, 286, 9856&#x2013;9864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3058977</ArticleId><ArticleId IdType="pubmed">21245135</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, De Lott LB, Nan B, Elner VM, Sawalha AH. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis. Ann Rheum Dis 75, 1196&#x2013;1202, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">26038090</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Gorelik G, Strickland FM, Richardson BC. Oxidative stress, T cell DNA methylation, and lupus. Arthritis Rheumatol 66, 1574&#x2013;1582, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4141415</ArticleId><ArticleId IdType="pubmed">24577881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawalha AH, Zhao M, Coit P, Lu Q. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol 215, 108410, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7139239</ArticleId><ArticleId IdType="pubmed">32276140</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaks Z, Perl A. Metabolic control of the epigenome in systemic Lupus erythematosus. Autoimmunity 47, 256&#x2013;264, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4034124</ArticleId><ArticleId IdType="pubmed">24128087</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Netea MG. Trained Innate Immunity, Epigenetics, and Covid-19. N Engl J Med 383, 1078&#x2013;1080, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32905684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihezie S. A., Mathew I. E., McBride D. W., Dienel A., Blackburn S. L., &amp; Thankamani Pandit P. K. (2021). Epigenetics in blood-brain barrier disruption. Fluids and barriers of the CNS, 18(1), 17. 10.1186/s12987-021-00250-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-021-00250-7</ArticleId><ArticleId IdType="pmc">PMC8025355</ArticleId><ArticleId IdType="pubmed">33823899</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigo K., Mantovani A., &amp; Bottazzi B. (2014). The yin-yang of long pentraxin PTX3 in inflammation and immunity. Immunology letters, 161(1), 38&#x2013;43. 10.1016/j.imlet.2014.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2014.04.012</ArticleId><ArticleId IdType="pmc">PMC7112810</ArticleId><ArticleId IdType="pubmed">24792672</ArticleId></ArticleIdList></Reference><Reference><Citation>Muffley L. A., Pan S. C., Smith A. N., Ga M., Hocking A. M., &amp; Gibran N. S. (2012). Differentiation state determines neural effects on microvascular endothelial cells. Experimental cell research, 318(16), 2085&#x2013;2093. 10.1016/j.yexcr.2012.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2012.06.002</ArticleId><ArticleId IdType="pmc">PMC3408560</ArticleId><ArticleId IdType="pubmed">22683922</ArticleId></ArticleIdList></Reference><Reference><Citation>Freese C., Hanada S., Fallier-Becker P., Kirkpatrick C. J., &amp; Linger R. E. (2017). Identification of neuronal and angiogenic growth factors in an in vitro blood-brain barrier model system: Relevance in barrier integrity and tight junction formation and complexity. Microvascular research, 111, 1&#x2013;11. 10.1016/j.mvr.2016.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2016.12.001</ArticleId><ArticleId IdType="pubmed">27988246</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo A., Maki T., Mandeville E. T., Liang A. C., Egawa N., Itoh K., Itoh N., Borlongan M., Holder J. C., Chuang T. T., McNeish J. D., Tomimoto H., Lok J., Lo E. H., &amp; Arai K. (2016). Astrocyte-Derived Pentraxin 3 Supports Blood-Brain Barrier Integrity Under Acute Phase of Stroke. Stroke, 47(4), 1094&#x2013;1100. 10.1161/STROKEAHA.115.012133</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.012133</ArticleId><ArticleId IdType="pmc">PMC4811738</ArticleId><ArticleId IdType="pubmed">26965847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesley U. V., Sutton I., Clark P. A., Cunningham K., Larrain C., Kuo J. S., &amp; Dempsey R. J. (2022). Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis. Brain research, 1776, 147752. 10.1016/j.brainres.2021.147752</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2021.147752</ArticleId><ArticleId IdType="pubmed">34906547</ArticleId></ArticleIdList></Reference><Reference><Citation>Siqueira M., Francis D., Gisbert D., Gomes F., &amp; Stipursky J. (2018). Radial Glia Cells Control Angiogenesis in the Developing Cerebral Cortex Through TGF-&#x3b2;1 Signaling. Molecular neurobiology, 55(5), 3660&#x2013;3675. 10.1007/s12035-017-0557-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0557-8</ArticleId><ArticleId IdType="pubmed">28523566</ArticleId></ArticleIdList></Reference><Reference><Citation>Breviario F., d&#x2019;Aniello E. M., Golay J., Peri G., Bottazzi B., Bairoch A., Saccone S., Marzella R., Predazzi V., &amp; Rocchi M. (1992). Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. The Journal of biological chemistry, 267(31), 22190&#x2013;22197.</Citation><ArticleIdList><ArticleId IdType="pubmed">1429570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazzini F., Peri G., Doni A., Dell&#x2019;Antonio G., Dal Cin E., Bozzolo E., D&#x2019;Auria F., Praderio L., Ciboddo G., Sabbadini M. G., Manfredi A. A., Mantovani A., &amp; Querini P. R. (2001). PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis and rheumatism, 44(12), 2841&#x2013;2850. 10.1002/1529-0131(200112)44:12&lt;2841::aid-art472&gt;3.0.co;2-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200112)44:12&lt;2841::aid-art472&gt;3.0.co;2-6</ArticleId><ArticleId IdType="pubmed">11762945</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusnati M., Camozzi M., Moroni E., Bottazzi B., Peri G., Indraccolo S., Amadori A., Mantovani A., &amp; Presta M. (2004). Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood, 104(1), 92&#x2013;99. 10.1182/blood-2003-10-3433</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-10-3433</ArticleId><ArticleId IdType="pubmed">15031207</ArticleId></ArticleIdList></Reference><Reference><Citation>Presta M., Foglio E., Churruca Schuind A., &amp; Ronca R. (2018). Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2. Frontiers in immunology, 9, 2327. 10.3389/fimmu.2018.02327</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02327</ArticleId><ArticleId IdType="pmc">PMC6187966</ArticleId><ArticleId IdType="pubmed">30349543</ArticleId></ArticleIdList></Reference><Reference><Citation>Meini S, Giani T, Tascini C. Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2. Mol Biol Rep 47, 8301&#x2013;8304, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486971</ArticleId><ArticleId IdType="pubmed">32920756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentzer S. J., Ackermann M., &amp; Jonigk D. (2022). Endothelialitis, Microischemia, and Intussusceptive Angiogenesis in COVID-19. Cold Spring Harbor perspectives in medicine, a041157. Advance online publication. 10.1101/cshperspect.a041157</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a041157</ArticleId><ArticleId IdType="pmc">PMC9524390</ArticleId><ArticleId IdType="pubmed">35534210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Mentzer S. J., Kolb M., &amp; Jonigk D. (2020). Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow. The European respiratory journal, 56(5), 2003147. 10.1183/13993003.03147-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03147-2020</ArticleId><ArticleId IdType="pmc">PMC7530910</ArticleId><ArticleId IdType="pubmed">33008942</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado F., Morales D., D&#xed;az-Papapietro C., Vald&#xe9;s C., Fernandez C., Valls N., Lazo M., Espinoza C., Gonz&#xe1;lez R., Guti&#xe9;rrez R., Jara &#xc1;., Romero C., Cerda O., &amp; C&#xe1;ceres M. (2022). Relationship Between Endothelial and Angiogenesis Biomarkers Envisage Mortality in a Prospective Cohort of COVID-19 Patients Requiring Respiratory Support. Frontiers in medicine, 9, 826218. 10.3389/fmed.2022.826218</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.826218</ArticleId><ArticleId IdType="pmc">PMC8966493</ArticleId><ArticleId IdType="pubmed">35372407</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathan G., Milagre C., Pearce O. M., Reynolds L. E., Hodivala-Dilke K., Leinster D. A., Zhong H., Hollingsworth R. E., Thompson R., Whiteford J. R., &amp; Balkwill F. (2015). Interleukin-6 Stimulates Defective Angiogenesis. Cancer research, 75(15), 3098&#x2013;3107. 10.1158/0008-5472.CAN-15-1227</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-15-1227</ArticleId><ArticleId IdType="pmc">PMC4527186</ArticleId><ArticleId IdType="pubmed">26081809</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes A., Corrales N., G&#xe1;lvez N., Bueno S. M., Kalergis A. M., &amp; Gonzalez P. A. (2020). Contribution of hypoxia inducible factor-1 during viral infections. Virulence, 11(1), 1482&#x2013;1500. 10.1080/21505594.2020.1836904</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2020.1836904</ArticleId><ArticleId IdType="pmc">PMC7605355</ArticleId><ArticleId IdType="pubmed">33135539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70(5):1469&#x2013;1480.</Citation><ArticleIdList><ArticleId IdType="pubmed">16887934</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsar B, Kanbay M, Afsar RE. Hypoxia inducible factor-1 protects against COVID-19: a hypothesis. Med Hypotheses. 2020;143:109857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7238987</ArticleId><ArticleId IdType="pubmed">32464493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Wu Y, Zhao M, et al. Role of HIF-1&#x3b1; in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2009;297(4):L631&#x2013;L640.</Citation><ArticleIdList><ArticleId IdType="pubmed">19592460</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperio G. E., Lye P., Mughis H., Hamada H., Bloise E., Lye S. J., &amp; Matthews S. G. (2021). Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells. Microvascular research, 138, 104232. 10.1016/j.mvr.2021.104232</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2021.104232</ArticleId><ArticleId IdType="pmc">PMC8372440</ArticleId><ArticleId IdType="pubmed">34416267</ArticleId></ArticleIdList></Reference><Reference><Citation>Walmsley SR, Print C, Farahi N, et al. Hypoxiainduced neutrophil survival is mediated by HIF-1&#x3b1;dependent NF-&#x3ba;B activity. J Exp Med. 2005;201 (1):105&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212759</ArticleId><ArticleId IdType="pubmed">15630139</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi-Rull&#xe1;n R. M., Javadov S., &amp; Fossati S. (2021). Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer&#x2019;s Disease. Cells, 10(11), 2903. 10.3390/cells10112903</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112903</ArticleId><ArticleId IdType="pmc">PMC8616424</ArticleId><ArticleId IdType="pubmed">34831125</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldendorf W. H., Cornford M. E., and Brown W. J. (1977). The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann. Neurol. 1, 409&#x2013;417. Doi: 10.1002/ana.410010502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410010502</ArticleId><ArticleId IdType="pubmed">617259</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll D. N., Hu H., Sun J., Lewis S. E., Simpkins J. W., &amp; Ren X. (2015). Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier. Stroke, 46(6), 1681&#x2013;1689. 10.1161/STROKEAHA.115.009099</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.009099</ArticleId><ArticleId IdType="pmc">PMC4418219</ArticleId><ArticleId IdType="pubmed">25922503</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe3;o P. R., Teixeira P. C., Schipper L., da Silva I., Santana Filho P., J&#xfa;nior L., Peres A., Gon&#xe7;alves da Fonseca S., Chagas Monteiro M., Lira F. S., Andrey Cipriani Frade M., Comerlato J., Comerlato C., Sant&#x2019;Anna F. H., Bessel M., Abreu C. M., Wendland E. M., &amp; Dorneles G. P. (2022). Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection. International immunopharmacology, 108, 108697. Advance online publication. 10.1016/j.intimp.2022.108697</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.108697</ArticleId><ArticleId IdType="pmc">PMC8920784</ArticleId><ArticleId IdType="pubmed">35405594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Zhang J., Schiavon C. R., He M., Chen L., Shen H., Zhang Y., Yin Q.,Cho Y., Andrade L., Shadel G. S., Hepokoski M., Lei T., Wang H., Zhang J., Yuan J. X., Malhotra A., Manor U., Wang S., Yuan Z. Y., &#x2026; Shyy J. Y. (2021).SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.Circulation research, 128(9), 1323&#x2013;1326. 10.1161/CIRCRESAHA.121.318902</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio J. D., Gulen M. F., Saidoune F., Thacker V. V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C., Goepfert C., de Leval L., Garnier C. V., Berezowska S., Dubois A., Gilliet M., &amp; Ablasser A. (2022). The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature, 603(7899), 145&#x2013;151. 10.1038/s41586-022-04421-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04421-w</ArticleId><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrester S. J., Preston K. J., Cooper H. A., Boyer M. J., Escoto K. M., Poltronetti A. J., Elliott K. J., Kuroda R., Miyao M., Sesaki H., Akiyama T., Kimura Y., Rizzo V., Scalia R., &amp; Eguchi S. (2020). Mitochondrial Fission Mediates Endothelial Inflammation. Hypertension (Dallas, Tex.: 1979), 76(1), 267&#x2013;276. 10.1161/HYPERTENSIONAHA.120.14686</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.14686</ArticleId><ArticleId IdType="pmc">PMC7289685</ArticleId><ArticleId IdType="pubmed">32389075</ArticleId></ArticleIdList></Reference><Reference><Citation>Jendrach M., Pohl S., V&#xf6;th M., Kowald A., Hammerstein P., &amp; Bereiter-Hahn J. (2005). Morpho-dynamic changes of mitochondria during ageing of human endothelial cells. Mechanisms of ageing and development, 126(6&#x2013;7), 813&#x2013;821. 10.1016/j.mad.2005.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2005.03.002</ArticleId><ArticleId IdType="pubmed">15888336</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns E. M., Kruckeberg T. W., Comerford L. E., &amp; Buschmann M. T. (1979). Thinning of capillary walls and declining numbers of endothelial mitochondria in the cerebral cortex of the aging primate, Macaca nemestrina. Journal of gerontology, 34(5), 642&#x2013;650. 10.1093/geronj/34.5.642</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/34.5.642</ArticleId><ArticleId IdType="pubmed">112144</ArticleId></ArticleIdList></Reference><Reference><Citation>Won J., Lee S., Park M., Kim T. Y., Park M. G., Choi B. Y., Kim D., Chang H., Kim V. N., &amp; Lee C. J. (2020). Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19). Experimental neurobiology, 29(2), 107&#x2013;119. 10.5607/en20009</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en20009</ArticleId><ArticleId IdType="pmc">PMC7237269</ArticleId><ArticleId IdType="pubmed">32156101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z., Umemura A., Sanchez-Lopez E., Liang S., Shalapour S., Wong J., He F., Boassa D., Perkins G., Ali S. R., McGeough M. D., Ellisman M. H., Seki E., Gustafsson A. B., Hoffman H. M., Diaz-Meco M. T., Moscat J., &amp; Karin M. (2016). NF-&#x3ba;B Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell, 164(5), 896&#x2013;910. 10.1016/j.cell.2015.12.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.057</ArticleId><ArticleId IdType="pmc">PMC4769378</ArticleId><ArticleId IdType="pubmed">26919428</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahira K., Haspel J. A., Rathinam V. A., Lee S. J., Dolinay T., Lam H. C., Englert J. A., Rabinovitch M., Cernadas M., Kim H. R., Fitzgerald K. A., Ryter S. W., &amp; Choi A. M. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature immunology, 12(3), 222&#x2013;230. 10.1038/ni.1980</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1980</ArticleId><ArticleId IdType="pmc">PMC3079381</ArticleId><ArticleId IdType="pubmed">21151103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Yazdi A. S., Menu P., &amp; Tschopp J. (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature, 469(7329), 221&#x2013;225. 10.1038/nature09663</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09663</ArticleId><ArticleId IdType="pubmed">21124315</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Zhang D., Hu D., Zhou X., &amp; Zhou Y. (2018). The role of mitochondria in NLRP3 inflammasome activation. Molecular immunology, 103, 115&#x2013;124. 10.1016/j.molimm.2018.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2018.09.010</ArticleId><ArticleId IdType="pubmed">30248487</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomello M., Pyakurel A., Glytsou C. et al. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol 21, 204&#x2013;224 (2020). 10.1038/s41580-020-0210-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0210-7</ArticleId><ArticleId IdType="pubmed">32071438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Chen W., Zhang Z., Deng Y., Lian J. Q., Du P., Wei D., Zhang Y.,Sun X. X., Gong L., Yang X., He L., Zhang L., Yang Z., Geng J. J., Chen R.,Zhang H., Wang B., Zhu Y. M., Nan G., &#x2026; Chen Z. N.(2020). CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal transduction and targeted therapy, 5(1), 283. 10.1038/s41392-020-00426-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Won J., Lee S., Park M., Kim T. Y., Park M. G., Choi B. Y., Kim D., Chang H., Kim V. N., &amp; Lee C. J. (2020). Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19). Experimental neurobiology, 29(2), 107&#x2013;119. 10.5607/en20009.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en20009</ArticleId><ArticleId IdType="pmc">PMC7237269</ArticleId><ArticleId IdType="pubmed">32156101</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman V. M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D. K., Bleicker T., Br&#xfc;nink S., Schneider J., Schmidt M. L., Mulders D. G., Haagmans B. L., van der Veer B., van den Brink S., Wijsman L., Goderski G., Romette J. L., Ellis J., Zambon M., Peiris M., &#x2026; Drosten C. (2020). Detection of 2019 novel coronavirus(2019-nCoV) by real-time RT-PCR. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(3), 2000045. 10.2807/1560-7917.ES.2020.25.3.2000045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia Sanchez C., Theel E., Binnicker M., Toledano M., &amp; McKeon A. (2021). Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes. Neurology, 97(23), e2262&#x2013;e2268. 10.1212/WNL.0000000000012931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012931</ArticleId><ArticleId IdType="pmc">PMC8671045</ArticleId><ArticleId IdType="pubmed">34635560</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R. W., Brown R. L., Benjamin L., Nortley R., Wiethoff S., Bharucha T., Jayaseelan D. L., Kumar G., Raftopoulos R. E., Zambreanu L., Vivekanandam V., Khoo A., Geraldes R., Chinthapalli K., Boyd E., Tuzlali H., Price G., Christofi G., Morrow J., McNamara P., &#x2026; Zandi M. S. (2020). The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain : a journal of neurology,143(10), 3104&#x2013;3120. 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D. H., Tsukahara T., Weinreb C., Lipovsek M., Van den Berge K., Gong B.,Chance R., Macaulay I. C., Chou H. J., Fletcher R. B., Das D., Street K., de Bezieux H. R., Choi Y. G., Risso D., Dudoit S., Purdom E., Mill J., Hachem R. A., Matsunami H., &#x2026; Datta S. R. (2020). Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Science advances, 6(31), eabc5801. 10.1126/sciadv.abc5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata F., Nakagawa S., Matsumoto J., &amp; Dohgu S. (2021). Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction. Frontiers in cellular neuroscience, 15, 661838. 10.3389/fncel.2021.661838</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.661838</ArticleId><ArticleId IdType="pmc">PMC8475767</ArticleId><ArticleId IdType="pubmed">34588955</ArticleId></ArticleIdList></Reference><Reference><Citation>Giepmans B. N., &amp; Moolenaar W. H. (1998). The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Current biology: CB, 8(16), 931&#x2013;934. 10.1016/s0960-9822(07)00375-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0960-9822(07)00375-2</ArticleId><ArticleId IdType="pubmed">9707407</ArticleId></ArticleIdList></Reference><Reference><Citation>Saras J., &amp; Heldin C. H. (1996). PDZ domains bind carboxy-terminal sequences of target proteins. Trends in biochemical sciences, 21(12), 455&#x2013;458. 10.1016/s0968-0004(96)30044-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0968-0004(96)30044-3</ArticleId><ArticleId IdType="pubmed">9009824</ArticleId></ArticleIdList></Reference><Reference><Citation> 
 https://covid19.who.int/
</Citation></Reference><Reference><Citation>WHO
2022: https://www.who.int/activities/tracking-SARS-CoV-2-variants</Citation></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G. F., Tan W., &amp; China Novel Coronavirus Investigating and Research Team (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine, 382(8), 727&#x2013;733. 10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation> 
 https://covid.cdc.gov/covid-data-tracker/#datatracker-home
.</Citation></Reference><Reference><Citation>CDC
2020: https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data/vbim-akqf</Citation></Reference><Reference><Citation>WHO, 2021: https://www.who.int/publications/i/item/WHO-WPE-GIH-2021.1</Citation></Reference><Reference><Citation>Sugiura A., McLelland G. L., Fon E. A., &amp; McBride H. M. (2014). A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. The EMBO journal, 33(19), 2142&#x2013;2156. 10.15252/embj.201488104</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201488104</ArticleId><ArticleId IdType="pmc">PMC4282503</ArticleId><ArticleId IdType="pubmed">25107473</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A., Guerra F., Calvani R., Coelho-Junior H. J., Bossola M., Landi F., Bernabei R., Bucci C., &amp; Marzetti E. (2020). Generation and Release of Mitochondrial-Derived Vesicles in Health, Aging and Disease. Journal of clinical medicine, 9(5), 1440. 10.3390/jcm9051440</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051440</ArticleId><ArticleId IdType="pmc">PMC7290979</ArticleId><ArticleId IdType="pubmed">32408624</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>